RAINMED-B (02297) released its performance for the year 2025, with a net loss attributable to shareholders of 77.083 million yuan, a year-on-year narrowing of 32.1%.

19:40 31/03/2026

Runmed-B (02297) released its annual performance for the year ending December 31, 2025, with revenue of 191.76 million yuan, a year-on-year decrease of 51.8%; the company's shareholders' share of losses was 77.08 million yuan, a year-on-year narrowing of 32.1%; basic loss per share was 0.06 yuan.

RAINMED-B(02297) released its annual performance for the year ending December 31, 2025, with revenue of 191.76 million yuan, a year-on-year decrease of 51.8%; the company's net loss attributable to shareholders was 77.083 million yuan, a year-on-year narrowing of 32.1%; basic loss per share was 0.06 yuan. The gross profit decreased by about 62.41% year-on-year to 9 million yuan for the year 2025, mainly due to a decrease in sales of the company's FlashPressure caFFR pressure sensors, FlashAngio caFFR systems, and FlashAngio caIMR systems. The company's gross profit margin decreased from 60.1% in 2024 to 46.9% in the same period of 2025, mainly due to a decrease in product sales volume while unit production costs remained high.

CHANGHONG JH (03991) announced its annual performance with a net profit of approximately HK$401 million, representing a year-on-year increase of 5.69%.

ISP Global (08487): Yuan Shuangshun resigns as executive director and authorized representative.

VISION SYNERGY (00627) announced annual performance, with a net loss attributable to shareholders of 168 million yuan, a year-on-year decrease of 80.29%.

CHANGHONG JH (03991) announced its annual performance with a net profit of approximately HK$401 million, representing a year-on-year increase of 5.69%.

ISP Global (08487): Yuan Shuangshun resigns as executive director and authorized representative.

VISION SYNERGY (00627) announced annual performance, with a net loss attributable to shareholders of 168 million yuan, a year-on-year decrease of 80.29%.